These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12597456)

  • 1. Biostatistical evaluation of focal hepatic preneoplasia.
    Kopp-Schneider A
    Toxicol Pathol; 2003; 31(1):121-5. PubMed ID: 12597456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing statistical hypotheses about rat liver foci.
    Morris RW
    Toxicol Pathol; 1989; 17(4 Pt 1):569-78. PubMed ID: 2697938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for parametric estimation of the number and size distribution of cell clusters from observations in a section plane.
    de Gunst MC; Luebeck EG
    Biometrics; 1998 Mar; 54(1):100-12. PubMed ID: 9544509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple elementary method for the quantification of focal liver lesions induced by carcinogens.
    Enzmann H; Edler L; Bannasch P
    Carcinogenesis; 1987 Feb; 8(2):231-5. PubMed ID: 3802406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in rats.
    Bishayee A; Chatterjee M
    Anticancer Res; 1995; 15(2):455-61. PubMed ID: 7763021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report.
    Ittrich C; Deml E; Oesterle D; Küttler K; Mellert W; Brendler-Schwaab S; Enzmann H; Schladt L; Bannasch P; Haertel T; Mönnikes O; Schwarz M; Kopp-Schneider A
    Toxicol Pathol; 2003; 31(1):60-79. PubMed ID: 12597450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
    Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
    Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation-promotion-initiation. Induction of neoplastic foci within islands of precancerous liver cells in the rat.
    Scherer E; Feringa AW; Emmelot P
    IARC Sci Publ; 1984; (56):57-66. PubMed ID: 6536610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of altered hepatic foci by 2,3',4,4',5-pentachlorobiphenyl in Sprague-Dawley female rats.
    Haag-Grönlund M; Wärngård L; Flodström S; Scheu G; Kronevi T; Ahlborg UG; Fransson-Steen R
    Fundam Appl Toxicol; 1997 Jan; 35(1):120-30. PubMed ID: 9024679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
    Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
    Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coadministration of phenobarbital sodium on N-nitrosodiethylamine-induced gamma-glutamyltransferase-positive foci and hepatocellular carcinoma in rats.
    Pereira MA; Herren-Freund SL; Britt AL; Khoury MM
    J Natl Cancer Inst; 1984 Mar; 72(3):741-4. PubMed ID: 6142138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.
    Campbell HA; Pitot HC; Potter VR; Laishes BA
    Cancer Res; 1982 Feb; 42(2):465-72. PubMed ID: 6120037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marriage of a medium-term liver model to surrogate markers--a practical approach for risk and benefit assessment.
    Moore MA; Tsuda H; Tamano S; Hagiwara A; Imaida K; Shirai T; Ito N
    Toxicol Pathol; 1999; 27(2):237-42. PubMed ID: 10207988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and modulation of hepatic preneoplasia and neoplasia in the rat by dehydroepiandrosterone.
    Mayer D; Forstner K; Kopplow K
    Toxicol Pathol; 2003; 31(1):103-12. PubMed ID: 12597454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of histochemically detectable altered hepatocyte foci to hepatic tumorigenesis.
    Peraino C; Staffeldt EF; Carnes BA; Ludeman VA; Blomquist JA; Vesselinovitch SD
    IARC Sci Publ; 1984; (56):37-55. PubMed ID: 6536601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.